The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Published Date: 29 Jan 2024

Without increasing toxicity, OS, PFS, and cancer-specific survival all increased.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines

2.

No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

3.

Pollution exposure may affect lung cancer in women who have never smoked

4.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

5.

Dense breasts: What it means and what women can do about screening


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot